SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-20-001135
Filing Date
2020-11-23
Accepted
2020-11-23 11:17:06
Documents
2
Period of Report
2020-11-19

Document Format Files

Seq Description Document Type Size
1 springbank_fm4nov192020.html 4  
1 springbank_fm4nov192020.xml 4 4393
2 POWER OF ATTORNEY brady_poa.htm EX-24 5815
  Complete submission text file 0000905718-20-001135.txt   11733
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Issuer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVOKE PHARMA, INC. 505 LOMAS SANTA FE DRIVE SOLANA BEACH CA 92075
Business Address
Brady Todd C (Reporting) CIK: 0001579179 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37718 | Film No.: 201335158